The Norwegian Radium Hospital Research Foundation

The Norwegian Radium Hospital Research Foundation (RF) invests in companies based on the continuing flow of state-of-the-art innovations from leading Nordic research institutions.

RF is an independent organisation founded in 1986 by The Norwegian Radium Hospital and the Norwegian Ministry of Health. The aim of RF is to strengthen cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital

Business concept
The Norwegian Radium Hospital Research Foundation is an experienced pre-seed investor and project developer focused on cancer. Far from being a passive investor, we take an active part in their further development. Our experienced team now manages an exciting balanced portfolio with particular strengths in novel therapeutics and vaccines.

Business opportunities

• RF invites early-stage biotech companies to contact us for further development, funding and commercialization of their product or technology. 
• RF seeks co-investors with interests in biotechnology for investment opportunities in a rapidly expanding and important field.

Building a strong biotech industry in Norway
The Norwegian Radium Hospital Research Foundation is actively engaged in several initiatives to secure a sound, research-based biotechnology industry in Norway. One of these initiatives is establishment of Oslo Cancer Cluster (OCC). RF is today the facilitator of OCC, providing the cluster with the necessary infrastructure and management team. See www.oslocancercluster.no